Epidermal Growth Factor Receptor as a Target for Chemotherapy

This publication has 31 references indexed in Scilit:

• Capecitabine: the new generation of fluoropyrimidines in colorectal cancer
  Expert Review of Anticancer Therapy, 2004
• Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
  New England Journal of Medicine, 2004
• Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy
  The Oncologist, 2002
• Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
  Cancer, 2002
• The EGFR family and its ligands in human cancer
  European Journal of Cancer, 2001
• Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
  Journal of Clinical Oncology, 2000
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
  The Lancet, 2000
• EGF receptor
  The International Journal of Biochemistry & Cell Biology, 1999
• Epidermal growth factor-related peptides and their receptors in human malignancies
  Critical Reviews in Oncology/Hematology, 1995
• The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer
  Cancer, 1993